FDA approves Teva's version of Yaz oral contraceptive

04/2/2009 | Globes (Israel)

The FDA approved Teva Pharmaceutical Industries' copy of Yaz, a birth-control pill developed by Bayer HealthCare Pharmaceuticals. Last year, Teva unit Barr Pharmaceuticals resolved a patent dispute with Bayer by signing a licensing agreement that allows the Israeli firm to launch its version July 1, 2011, or earlier in other circumstances.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC